Pfizer Inc (PFE)

$25.53 -0.90 (-3.41%)
Market Cap 150.27B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 8.08
Forward PE 8.12
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 111,695,400
Avg Vol 68,882,328
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 35%
Beta 0.46
Analysts Sell
Price Target $28.14

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
reyofhope
reyofhope Dec. 17 at 4:12 PM
$PFE wish I can buy more.
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 17 at 3:46 PM
$PFE another day of only following the market when it goes down
0 · Reply
Tiger65
Tiger65 Dec. 17 at 3:34 PM
$PFE Good news in oncology sector. $MRNA up 5 % on good news (vaccines against MS and Covid). Sector shift seems to be going on. Hold strong here.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:31 PM
Morgan Stanley has adjusted their stance on Pfizer ( $PFE ), setting the rating to Equal-Weight with a target price of 28 → 27.
0 · Reply
Willieberich
Willieberich Dec. 17 at 3:17 PM
$PFE beware of people that post here all day long !!to much time on there hands .or they try to get in your head .just a little something to be aware of ..
0 · Reply
isabellabryant03
isabellabryant03 Dec. 17 at 3:10 PM
$PFE BioMainz I keep it simple, the market pays for prevention narratives, 82 percent advanced adenomas and that high grade dysplasia 100 percent line is the prevention story in one sentence, catalyst wise those stats create repeatable attention waves every time someone reposts them, tech wise the base is still intact around 1.00, once buyers flip 1.03 to 1.05 into support the risk reward changes because dips stop getting sold and start getting bought 😏
0 · Reply
Willieberich
Willieberich Dec. 17 at 3:10 PM
$PFE just added more ..more price targets are at 30 plus . I'll stay here .
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 3:01 PM
$PFE drops over 3% on bleak 2026 outlook — what’s behind the sell-off? 📉 • Revenue projections ($59.5-$62.5B) barely match expectations, with a soft EPS forecast falling below consensus 📊 • COVID-19 product sales set to decline by $1.5 billion, plus looming patent cliffs spell trouble for long-term growth 🚧 Full analysis here 👉 https://www.zacks.com/stock/news/2805652/pfizer-issues-soft-2026-view-what-does-it-mean-for-the-stocks-future?cid=sm-stocktwits-2-2805652-body-25151&ADID=SYND_STOCKTWITS_TWEET_2_2805652_BODY_25151
1 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 17 at 2:53 PM
$PFE legit comical
0 · Reply
Typecheck
Typecheck Dec. 17 at 2:53 PM
$PFE now I think about it. Pfizer and Novo fighting over metsera is really like two hobos fighting over a leftover pizza. Or two 40 year old maids fight over a middle aged, potbellied, and balding guy.
1 · Reply
Latest News on PFE
Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back

Dec 17, 2025, 10:14 AM EST - 1 hour ago

Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back

MRK

PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Dec 17, 2025, 6:45 AM EST - 4 hours ago

PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Dec 16, 2025, 2:39 PM EST - 20 hours ago

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Pfizer falls on disappointing guidance

Dec 16, 2025, 12:33 PM EST - 22 hours ago

Pfizer falls on disappointing guidance

Pfizer's modest 2026 outlook shows its big investments will take time to pay off

Dec 16, 2025, 10:12 AM EST - 1 day ago

Pfizer's modest 2026 outlook shows its big investments will take time to pay off

Here's why Pfizer is revising its revenue forecasts

Dec 16, 2025, 7:47 AM EST - 1 day ago

Here's why Pfizer is revising its revenue forecasts

Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.

Dec 16, 2025, 7:25 AM EST - 1 day ago

Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.

Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings

Dec 16, 2025, 7:16 AM EST - 1 day ago

Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings

Pfizer forecasts 2026 profit below expectations on lower COVID product sales

Dec 16, 2025, 6:54 AM EST - 1 day ago

Pfizer forecasts 2026 profit below expectations on lower COVID product sales

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Dec 16, 2025, 6:45 AM EST - 1 day ago

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million

Dec 15, 2025, 8:24 AM EST - 2 days ago

Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million

ADPT

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

Dec 15, 2025, 8:00 AM EST - 2 days ago

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

ADPT

Pfizer Declares First-Quarter 2026 Dividend

Dec 12, 2025, 12:00 PM EST - 4 days ago

Pfizer Declares First-Quarter 2026 Dividend

Dividend Harvesting Portfolio Week 249: $24,900 Allocated, $2,646.53 In Projected Dividends

Dec 12, 2025, 8:45 AM EST - 5 days ago

Dividend Harvesting Portfolio Week 249: $24,900 Allocated, $2,646.53 In Projected Dividends

AMLP MO MSTY OHI

Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial

Dec 12, 2025, 7:24 AM EST - 5 days ago

Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial

Pfizer to cut hundreds of jobs in Switzerland to reduce costs, Bloomberg News reports

Dec 10, 2025, 11:38 AM EST - 6 days ago

Pfizer to cut hundreds of jobs in Switzerland to reduce costs, Bloomberg News reports

TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer

Dec 10, 2025, 8:15 AM EST - 7 days ago

TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer

Will Pfizer's YaoPharma deal deliver a powerful new oral obesity pill?

Dec 9, 2025, 3:30 PM EST - 7 days ago

Will Pfizer's YaoPharma deal deliver a powerful new oral obesity pill?

Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Dec 9, 2025, 11:14 AM EST - 8 days ago

Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons

Dec 9, 2025, 10:59 AM EST - 8 days ago

Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons

Pfizer: The Most Powerful Drug Pipeline In Pharma Could Deliver Major Long-Term Gains

Dec 9, 2025, 10:45 AM EST - 8 days ago

Pfizer: The Most Powerful Drug Pipeline In Pharma Could Deliver Major Long-Term Gains

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

Dec 9, 2025, 10:15 AM EST - 8 days ago

Here's 12 Ideal 'Safer' December Dividend Dogs Of The S&P500

AES AMCR ARE CAG CPB D DOC

Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

Dec 9, 2025, 6:55 AM EST - 8 days ago

Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

Pfizer partners with YaoPharma for weight management treatment

Dec 9, 2025, 6:38 AM EST - 8 days ago

Pfizer partners with YaoPharma for weight management treatment

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma

Dec 9, 2025, 6:30 AM EST - 8 days ago

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma

HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors

Dec 6, 2025, 5:15 PM EST - 10 days ago

HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors

Pfizer: The Market Is Still Wrong About It

Dec 5, 2025, 9:00 AM EST - 12 days ago

Pfizer: The Market Is Still Wrong About It

17 dividend-stock bargains from a value manager with a stellar track record

Dec 2, 2025, 12:11 PM EST - 14 days ago

17 dividend-stock bargains from a value manager with a stellar track record

BMY CIVI CMCSA CVS MOS MRK MTH

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 15 days ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA NVAX

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 15 days ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA NVAX

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

Dec 1, 2025, 10:00 AM EST - 16 days ago

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters

Nov 30, 2025, 6:13 AM EST - 17 days ago

Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters

Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December

Nov 29, 2025, 11:59 PM EST - 17 days ago

Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December

MA AVGO

8 'Safer' Dividend Buys In Barron's 23 Better November Bets Than T-Bills

Nov 28, 2025, 11:00 AM EST - 19 days ago

8 'Safer' Dividend Buys In Barron's 23 Better November Bets Than T-Bills

BBB BBY BMY CAG EQR KEY KIM

Final Trade: DAL, AXP, PFE, HMY

Nov 26, 2025, 6:20 PM EST - 20 days ago

Final Trade: DAL, AXP, PFE, HMY

AXP DAL HMY

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings

Nov 26, 2025, 12:30 PM EST - 20 days ago

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings

VALN

JNJ Stock vs. PFE Stock: Which Pharmaceutical Giant Is A Better Buy?

Nov 25, 2025, 5:20 AM EST - 22 days ago

JNJ Stock vs. PFE Stock: Which Pharmaceutical Giant Is A Better Buy?

JNJ

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

Nov 21, 2025, 1:24 PM EST - 25 days ago

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

Pfizer Crosses Below Key Moving Average Level

Nov 20, 2025, 4:05 PM EST - 26 days ago

Pfizer Crosses Below Key Moving Average Level

$100,000 In The S&P 500's 5 Cheapest Healthcare Stocks, 4% Average Dividend Yield

Nov 20, 2025, 11:17 AM EST - 27 days ago

$100,000 In The S&P 500's 5 Cheapest Healthcare Stocks, 4% Average Dividend Yield

AMGN BMY GILD IVV MRK SPY VOO

October Readers Identified 10 Ideal "Safer" Dividends In 39 Dogs

Nov 19, 2025, 5:43 PM EST - 27 days ago

October Readers Identified 10 Ideal "Safer" Dividends In 39 Dogs

CAG CIM EPD HAFN HRL IPG KEY

Pfizer: Is This Pharma Giant Finally A Bargain

Nov 19, 2025, 3:51 PM EST - 27 days ago

Pfizer: Is This Pharma Giant Finally A Bargain

Pfizer in $41.5 million settlement with Texas over ADHD drug

Nov 19, 2025, 10:31 AM EST - 4 weeks ago

Pfizer in $41.5 million settlement with Texas over ADHD drug

Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 19, 2025, 6:58 AM EST - 4 weeks ago

Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

Nov 18, 2025, 4:21 PM EST - 4 weeks ago

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

AZN JNJ LLY MDT MRK NVO OLMA

Global drugmakers rush to boost US presence as tariff threat looms

Nov 18, 2025, 8:25 AM EST - 4 weeks ago

Global drugmakers rush to boost US presence as tariff threat looms

ABBV AMGN AZN BIIB GILD GSK JNJ

US-Saudi event to include CEOs from Chevron, Qualcomm, Pfizer, source says

Nov 17, 2025, 6:54 PM EST - 4 weeks ago

US-Saudi event to include CEOs from Chevron, Qualcomm, Pfizer, source says

CVX QCOM CSCO GD

3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

Nov 17, 2025, 4:05 PM EST - 4 weeks ago

3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

INCY PPH VRTX XBI XLV

Activist Starboard sells Pfizer stake after pushing for changes

Nov 14, 2025, 6:33 PM EST - 4 weeks ago

Activist Starboard sells Pfizer stake after pushing for changes

Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman

Nov 14, 2025, 3:19 PM EST - 4 weeks ago

Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman

ABBV AZN JNJ LLY MRK NVO XLV

reyofhope
reyofhope Dec. 17 at 4:12 PM
$PFE wish I can buy more.
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 17 at 3:46 PM
$PFE another day of only following the market when it goes down
0 · Reply
Tiger65
Tiger65 Dec. 17 at 3:34 PM
$PFE Good news in oncology sector. $MRNA up 5 % on good news (vaccines against MS and Covid). Sector shift seems to be going on. Hold strong here.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:31 PM
Morgan Stanley has adjusted their stance on Pfizer ( $PFE ), setting the rating to Equal-Weight with a target price of 28 → 27.
0 · Reply
Willieberich
Willieberich Dec. 17 at 3:17 PM
$PFE beware of people that post here all day long !!to much time on there hands .or they try to get in your head .just a little something to be aware of ..
0 · Reply
isabellabryant03
isabellabryant03 Dec. 17 at 3:10 PM
$PFE BioMainz I keep it simple, the market pays for prevention narratives, 82 percent advanced adenomas and that high grade dysplasia 100 percent line is the prevention story in one sentence, catalyst wise those stats create repeatable attention waves every time someone reposts them, tech wise the base is still intact around 1.00, once buyers flip 1.03 to 1.05 into support the risk reward changes because dips stop getting sold and start getting bought 😏
0 · Reply
Willieberich
Willieberich Dec. 17 at 3:10 PM
$PFE just added more ..more price targets are at 30 plus . I'll stay here .
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 3:01 PM
$PFE drops over 3% on bleak 2026 outlook — what’s behind the sell-off? 📉 • Revenue projections ($59.5-$62.5B) barely match expectations, with a soft EPS forecast falling below consensus 📊 • COVID-19 product sales set to decline by $1.5 billion, plus looming patent cliffs spell trouble for long-term growth 🚧 Full analysis here 👉 https://www.zacks.com/stock/news/2805652/pfizer-issues-soft-2026-view-what-does-it-mean-for-the-stocks-future?cid=sm-stocktwits-2-2805652-body-25151&ADID=SYND_STOCKTWITS_TWEET_2_2805652_BODY_25151
1 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 17 at 2:53 PM
$PFE legit comical
0 · Reply
Typecheck
Typecheck Dec. 17 at 2:53 PM
$PFE now I think about it. Pfizer and Novo fighting over metsera is really like two hobos fighting over a leftover pizza. Or two 40 year old maids fight over a middle aged, potbellied, and balding guy.
1 · Reply
simonds
simonds Dec. 17 at 2:52 PM
$PFE Prbably go down below $24/sh
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 17 at 2:49 PM
$PFE controlled walk downs every single day
1 · Reply
Namhguab
Namhguab Dec. 17 at 2:42 PM
$PFE Bourla has got to go.
0 · Reply
Tfizzle
Tfizzle Dec. 17 at 2:40 PM
$PFE
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 17 at 2:38 PM
$PFE I’ve never in my life owned something worse than this
1 · Reply
CuriouslyPanda
CuriouslyPanda Dec. 17 at 2:38 PM
$PFE $PFE $PFE good grief...
1 · Reply
constance1
constance1 Dec. 17 at 2:36 PM
$BDRX $OCG $PAVS $PFE
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Dec. 17 at 2:36 PM
$PFE 💨
0 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 17 at 2:25 PM
$PFE can’t wait to suck today
0 · Reply
SPG565
SPG565 Dec. 17 at 2:15 PM
$PFE Was driven down for cheaper buys. Hope you added.
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 2:01 PM
$PFE outlook just rattled the market — and it’s not hard to see why. ⚠️ Management’s 2026 revenue and EPS guidance came in below expectations, as COVID-19 demand continues to fade and patent losses start to bite. That combo is clearly unsettling investors. See the full breakdown of what’s pressuring Pfizer’s outlook 👉 https://www.zacks.com/stock/news/2805652/pfizer-issues-soft-2026-view-what-does-it-mean-for-the-stocks-future?cid=sm-stocktwits-2-2805652-teaser-25149&ADID=SYND_STOCKTWITS_TWEET_2_2805652_TEASER_25149
0 · Reply
dogDazeSummer
dogDazeSummer Dec. 17 at 1:39 PM
$IFRX Very sad to see influenza impact given vaccine rollout of COVID has created global vaccine hesitancy. $DJT operation warp speed should not be synonymous with creating a vaccine. What exactly did Trump promise $PFE $MRNA and why are these agreements confidential / not public records? https://torontosun.com/news/local-news/three-children-die-of-flu/wcm/683db835-e92f-486f-9daf-2bb3ac12dbe5#
0 · Reply